Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	68.67	110.96	-65.78
Graham Fair Price	-76.57	1.24	5.28
PEG	-8173.51	-0.72	< 0.005
Price/Book	7.32	1.81	1.69
Price/Cash Flow	593.15	2065.35	-297.97
Prices/Earnings	1141.58	76.88	-6.19
Price/Sales	-0.58	18.97	19.08
Price/FCF	593.15	2065.35	-297.97
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	678.78	0.31	-0.04
Operating Margin	-93.53	0.05	-0.85
ROA	-91.60	< 0.005	-0.05
ROE	-0.07	< 0.005	-91.36
ROIC	-0.06	< 0.005	-92.08
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.27	-0.23	20.00
Dividends QOQ	-0.44	0.22	-49.28
EBIT QOQ	-5.74	1.07	-81.39
EPS QOQ	-7.12	1.07	-84.99
FCF QOQ	-1.38	1.15	-16.49
Revenue QOQ	0.03	0.07	113.69
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	122.66	158.19	28.97
Days Sales Outstanding (DSO)	86.81	94.30	8.62
Inventory Turnover	0.73	0.57	-22.46
Debt/Capitalization	0.16	0.19	23.06
Quick Ratio	1.04	1.39	32.77
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.27	3.40	-20.30
Cash	1.07	1.27	18.81
Capex	< 0.005	-0.01	-2595.64
Free Cash Flow	-0.02	< 0.005	-87.66
Revenue	0.38	0.32	-13.96
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.45	1.49	2.19
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.66	-2.92	9.68
Naive Interpretation	Member

06 - Financial Health · Weak

Rating